FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to urology, and aims at predicting the risk of recurrence of urolithiasis at the stage of primary calcium oxalate nephrolithiasis. In a preoperative patient, blood serum is examined for levels of parathyroid hormone-related protein (PTHrP), osteopontin, vitamin D. If values of PTHrP ≥ 31.8 pg/ml, osteopontin ≤ 0.6 ng/ml, vitamin D ≤ 12.1 ng/ml in complex predict high risk of recurrence of urolithiasis in postoperative period.
EFFECT: invention provides more accurate prediction of developing recurrent nephrolithiasis in patients with primary single- or bilateral nephrolithiasis.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RECURRENCE OF STONE FORMATION IN PATIENTS WITH UROLITHIASIS | 2021 |
|
RU2779371C1 |
| METHOD FOR DETERMINING THE RISK OF CALCIINATE DEVELOPMENT IN CASE OF CYSTIC OF KIDNEY DISEASES OF CHILDREN | 2017 |
|
RU2649125C1 |
| METHOD OF UROLITHIASIS RECURRENCE TREATMENT AND PREVENTION FOR MEN | 2008 |
|
RU2371182C1 |
| METHOD OF DETERMINING DEGREE OF SEVERITY OF URIC UROLITHIASIS | 2012 |
|
RU2517221C1 |
| ENLARGED PLASTIC OF PELVIS OF INTRARENAL TYPE | 2018 |
|
RU2728942C2 |
| METHOD FOR PROPHYLAXIS OF RELAPSE LITHIASIS | 2006 |
|
RU2320368C1 |
| METHOD FOR EXCISION OF RESIDUAL CONCREMENTS IN PATIENTS WHO SUSTAINED SURGICAL PROCEDURE | 2008 |
|
RU2376017C1 |
| METHOD OF REMOVING OXALATE URINARI STONES IN PATIENTS WITH UROLYTHIASIS | 2009 |
|
RU2432970C2 |
| METHOD FOR PREDICTION OF EFFICIENCY OF SURGICAL METHODS OF PRIMARY HYPERPARATHYROIDISM TREATMENT | 2018 |
|
RU2697109C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF CHRONIC KIDNEY DISEASE AFTER REMOTE SHOCK-WAVE LITHOTRIPSY | 2016 |
|
RU2637424C1 |
